Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

The WEGOVY market has experienced significant growth, driven by rising obesity rates and increasing demand for effective weight-loss treatments. Novo Nordisk's blockbuster drug has seen strong ...

As weight loss drugs continue to grow in popularity in the U.S., some health leaders are warning about fake drugs on the ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Ozempic, for diabetes, and Wegovy, for weight loss, use the active ingredient semaglutide. All four drugs are part of a GLP-1 class of treatments that has shown unprecedented results for helping ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

A major new study has found that women over 55 are leading the way in weight loss –outperforming younger users of Wegovy and Mounjaro ... over several months lost 1–3 BMI units more and ...